Virpax Pharmaceuticals, Inc.
VRPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12 | -$15 | -$22 | -$12 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $135 | $1 | $1 | $1 |
| Change in WC | -$5 | $4 | $3 | -$3 |
| Other Non-Cash | -$16,831 | $1 | $1 | -$0 |
| Operating Cash Flow | -$16,713 | -$10 | -$18 | -$15 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$2 |
| Stock Issued | $6 | $0 | $0 | $58 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,078 | $0 | $0 | -$5 |
| Financing Cash Flow | $9,084 | $0 | $0 | $51 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$7,628 | -$10 | -$18 | $37 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,142 | $19 | $37 | $0 |
| End Cash | $1,513 | $9 | $19 | $37 |
| Free Cash Flow | -$16,713 | -$10 | -$18 | -$15 |